Wedbush Upgrades Nu Skin Enterprises (NUS) to Outperform; Expectation of Successful Major Upcoming Product Launch
Tweet Send to a FriendGet Alerts NUS Hot Sheet
Price: $61.37 -1.52%
Rating Summary:
4 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Rating Summary:
4 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Trade NUS Now!
Wedbush upgraded Nu Skin Enterprises (NYSE: NUS) from Neutral to Outperform, price target raised from $40 to $48.
Wedbush analyst says, "Expect major upcoming product launches to be key fundamental catalyst to further strengthen recruiting trends and distributor productivity, as well as deliver upside to consensus forecasts in 2012. Based on highly favorable feedback and encouraging pre-launch enthusiasm from senior-level Nu Skin distributors we have surveyed, we believe the upcoming fall launches of a new ageLOC skin care product for the body (and related new Galvanic Spa device), and a new nutritional supplement called R2, will act as key fundamental catalysts to earnings performance in upcoming quarters...we are increasing our 2012 forecasts for revenue, to $1.820 billion from $1.794 billion, and for EPS, to $2.93 from $2.85."
For more ratings news on Nu Skin Enterprises click here and for the rating history of Nu Skin Enterprises click here.
Shares of Nu Skin Enterprises closed at $42.25 yesterday, with a 52 week range of $25.50-$42.73.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Wedbush analyst says, "Expect major upcoming product launches to be key fundamental catalyst to further strengthen recruiting trends and distributor productivity, as well as deliver upside to consensus forecasts in 2012. Based on highly favorable feedback and encouraging pre-launch enthusiasm from senior-level Nu Skin distributors we have surveyed, we believe the upcoming fall launches of a new ageLOC skin care product for the body (and related new Galvanic Spa device), and a new nutritional supplement called R2, will act as key fundamental catalysts to earnings performance in upcoming quarters...we are increasing our 2012 forecasts for revenue, to $1.820 billion from $1.794 billion, and for EPS, to $2.93 from $2.85."
For more ratings news on Nu Skin Enterprises click here and for the rating history of Nu Skin Enterprises click here.
Shares of Nu Skin Enterprises closed at $42.25 yesterday, with a 52 week range of $25.50-$42.73.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: BofA/Merrill Lynch Upgrades Adobe (ADBE) to Buy
- Barclays Upgrades CEMEX (CX) to Overweight
- Jabil Circuit (JBL) Tops Q3 EPS by 2c; Issues Light Q4 Outlook; Will Realign Global Ops
Create E-mail Alert Related Categories
UpgradesRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
